Marksans Pharma (MARKSANS) Share News & Alerts
Every article that mentions MARKSANS is analysed by our AI, which assigns a sentiment and tracks the actual price move after the alert fires.
Buy, Sell Or Hold: Coforge, Samvardhana, Tata Power, Marksans Pharma, PNB — Ask Profit
▲ Bullish +1.5%
Marksans Pharma's trading levels were highlighted, which may attract short-term retail swing traders without altering its long-term fundamental value.
Marksans Pharma soars after Q4 PAT jumps 64% YoY
▲ Bullish +3.69%
Marksans Pharma's Q4 net profit jumped over 64% YoY alongside record EBITDA margins of 20.4%, heavily beating management guidelines. This massive operating leverage and shift toward high-margin US OTC store brands act as an immediate fundamental breakout trigger. Expect multi-day positional momentum to remain highly bullish over a 1 to 3-week trading horizon.
Three pharma stocks where FIIs raised stake in the March quarter
▲ Bullish +5.43%
FII holding more than doubled from 8.13% to 16.76% in a single quarter, reflecting massive institutional conviction in its UK/US product pipeline and OTC growth. This significant absorption of supply by 'strong hands' typically leads to a multi-month re-rating as the float reduces and visibility on earnings execution improves.
Get real-time alerts for MARKSANS
Add MARKSANS to your portfolio and receive instant AI-powered news alerts on your phone.
Set up free alerts →Explore More
AI Technical Analysis Alert History Other Bullish Stocks Today’s Trending